• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿肾损伤分子-1作为儿童循环衰竭后急性肾损伤的潜在生物标志物

Urine KIM-1 as a Potential Biomarker of Acute Renal Injury After Circulatory Collapse in Children.

作者信息

Assadi Farahnak, Sharbaf Fatemeh Ghane

机构信息

Department of Pediatrics, Section of Nephrology, Mashhad University of Medical Sciences, Mashhad, Iran.

出版信息

Pediatr Emerg Care. 2019 Feb;35(2):104-107. doi: 10.1097/PEC.0000000000000886.

DOI:10.1097/PEC.0000000000000886
PMID:27741065
Abstract

OBJECTIVES

Serum creatinine (SCr) is a late marker of acute kidney injury (AKI) due to the lag time between initiating injury and loss of function. We assessed the ability of urinary interleukin-18 (IL-18), kidney injury molecule-1 (KIM-1), and neutrophil gelatinase-associated lipocalin (NGAL) to predict AKI in critically ill children with circulatory collapse.

METHODS

Serum creatinine, estimated creatinine clearance (eCrCL), urine IL-18, KIM-1, and NGAL values were measured in 86 children with circulatory collapse on the day of admission, and the results were compared with those obtained 6 days later. Acute kidney injury was defined as a decrease in eCrCL of greater than 25% within the first 48 hours of enrollment. Areas under the curve (AUC) for receiver operating characteristic curve were calculated for the early detection of AKI.

RESULTS

Mean SCr concentration did not differ significantly during the first 6 days of hospital admission. In contrast, mean urine concentrations of IL-18, KIM-1, and NGAL rose significantly from day of admission to the sixth day of hospital stay (P < 0.001). Urinary KIM-1 emerged as having the strongest performance for the early detection of AKI, followed by NGAL, IL-18, and eCrCL. Urinary KIM-1 displayed the highest AUC of 0.81 (95% confidence interval [CI], 0.76-0.93; P < 0.001) for the early detection of AKI after circulatory collapse, followed by NGAL (0.77% CI, 0.70-0.84) and IL-18 (0.69% CI, 0.48-0.64).

CONCLUSIONS

Of a panel of 3 promising urinary biomarkers, KIM-1 demonstrated the best performance in predicting AKI in children with circulatory collapse before a change in SCr or eCrCL becomes apparent.

摘要

目的

由于从开始损伤到功能丧失存在滞后时间,血清肌酐(SCr)是急性肾损伤(AKI)的晚期标志物。我们评估了尿白细胞介素-18(IL-18)、肾损伤分子-1(KIM-1)和中性粒细胞明胶酶相关脂质运载蛋白(NGAL)预测循环衰竭危重症儿童发生AKI的能力。

方法

对86例循环衰竭儿童入院当天测定血清肌酐、估算肌酐清除率(eCrCL)、尿IL-18、KIM-1和NGAL值,并将结果与6天后获得的结果进行比较。急性肾损伤定义为入组后48小时内eCrCL下降超过25%。计算用于早期检测AKI的受试者工作特征曲线下面积(AUC)。

结果

入院后头6天平均SCr浓度无显著差异。相比之下,从入院当天到住院第6天,尿IL-18、KIM-1和NGAL的平均浓度显著升高(P<0.001)。尿KIM-1在早期检测AKI方面表现最强,其次是NGAL、IL-18和eCrCL。尿KIM-1在循环衰竭后早期检测AKI的AUC最高,为0.81(95%置信区间[CI],0.76 - 0.93;P<0.001),其次是NGAL(0.77%CI,0.70 - 0.84)和IL-18(0.69%CI,0.48 - 0.64)。

结论

在一组有前景的尿生物标志物中,KIM-1在SCr或eCrCL出现明显变化之前,对预测循环衰竭儿童发生AKI表现最佳。

相似文献

1
Urine KIM-1 as a Potential Biomarker of Acute Renal Injury After Circulatory Collapse in Children.尿肾损伤分子-1作为儿童循环衰竭后急性肾损伤的潜在生物标志物
Pediatr Emerg Care. 2019 Feb;35(2):104-107. doi: 10.1097/PEC.0000000000000886.
2
Performance of Serum Creatinine and Kidney Injury Biomarkers for Diagnosing Histologic Acute Tubular Injury.血清肌酐和肾损伤生物标志物在诊断组织学急性肾小管损伤中的表现
Am J Kidney Dis. 2017 Dec;70(6):807-816. doi: 10.1053/j.ajkd.2017.06.031. Epub 2017 Aug 24.
3
Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury.尿钙卫蛋白、肾损伤分子-1和中性粒细胞明胶酶相关脂质运载蛋白用于预测小儿急性肾损伤的不良结局
Eur J Pediatr. 2017 Jun;176(6):745-755. doi: 10.1007/s00431-017-2907-y. Epub 2017 Apr 14.
4
Urinary biomarkers of cell cycle arrest are delayed predictors of acute kidney injury after pediatric cardiopulmonary bypass.细胞周期阻滞的尿生物标志物是小儿体外循环后急性肾损伤的延迟预测因子。
Pediatr Nephrol. 2017 Dec;32(12):2351-2360. doi: 10.1007/s00467-017-3748-7. Epub 2017 Jul 28.
5
Evaluation of urinary neutrophil gelatinase-associated lipocalin and urinary kidney injury molecule-1 as biomarkers of renal function in cancer patients treated with cisplatin.评价中性粒细胞明胶酶相关脂质运载蛋白和尿肾损伤分子-1 作为顺铂治疗的癌症患者肾功能的生物标志物。
J Oncol Pharm Pract. 2020 Oct;26(7):1643-1649. doi: 10.1177/1078155220901756. Epub 2020 Feb 11.
6
Urinary neutrophil gelatinase-associated lipocalin identifies critically ill young children with acute kidney injury following intensive care admission: a prospective cohort study.尿中性粒细胞明胶酶相关脂质运载蛋白可识别重症监护病房入院后发生急性肾损伤的危重症幼儿:一项前瞻性队列研究。
Crit Care. 2015 Apr 21;19(1):181. doi: 10.1186/s13054-015-0910-0.
7
Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.尿肾损伤分子 1 和中性粒细胞明胶酶相关脂质运载蛋白对梗阻性肾病患者急性肾损伤的诊断性能。
Nephrology (Carlton). 2014 Apr;19(4):186-94. doi: 10.1111/nep.12173.
8
Assessment of urinary kidney injury molecule-1 and interleukin-18 in the early post-burn period to predict acute kidney injury for various degrees of burn injury.烧伤后早期尿肾损伤分子-1和白细胞介素-18的评估对不同程度烧伤所致急性肾损伤的预测作用
BMC Nephrol. 2015 Aug 18;16:142. doi: 10.1186/s12882-015-0140-3.
9
Implication of combined urinary biomarkers in early diagnosis of acute kidney injury following percutaneous coronary intervention.联合尿液生物标志物在经皮冠状动脉介入治疗后急性肾损伤早期诊断中的意义
Clin Nephrol. 2013 Feb;79(2):85-92. doi: 10.5414/CN106852.
10
Novel urinary biomarkers and the early detection of acute kidney injury after open cardiac surgeries.新型尿液生物标志物与心脏直视手术后急性肾损伤的早期检测
J Crit Care. 2017 Aug;40:171-177. doi: 10.1016/j.jcrc.2017.03.029. Epub 2017 Apr 6.

引用本文的文献

1
Novel acute kidney injury biomarkers and their utility in children and adolescents-overview.新型急性肾损伤生物标志物及其在儿童和青少年中的应用——综述
Ital J Pediatr. 2025 May 28;51(1):158. doi: 10.1186/s13052-025-02005-8.
2
Can Novel Biomarkers Effectively Predict Acute Kidney Injury in Liver or Kidney Transplant Recipients?新型生物标志物能否有效预测肝或肾移植受者的急性肾损伤?
Int J Mol Sci. 2024 Nov 10;25(22):12072. doi: 10.3390/ijms252212072.
3
Sex Differences on the Pharmacokinetics of Drugs for Children with Chronic Kidney Disease: A Narrative Review.
慢性肾脏病患儿药物药代动力学的性别差异:一项叙述性综述。
Adv Pharm Bull. 2024 Oct;14(3):537-542. doi: 10.34172/apb.2024.056. Epub 2024 Jun 30.
4
Exploring the Utility of Urinary Creatinine Adjustment for KIM-1, NGAL, and Cystatin C for the Assessment of Kidney Function: Insights from the C-KidnEES Cohort.探索尿肌酐校正对KIM-1、中性粒细胞明胶酶相关脂质运载蛋白(NGAL)和胱抑素C评估肾功能的效用:来自C-KidnEES队列的见解。
Children (Basel). 2023 Dec 22;11(1):15. doi: 10.3390/children11010015.
5
Pre-clinical evaluation of biomarkers for the early detection of nephrotoxicity following alpha-particle radioligand therapy.α 粒子放射性配体治疗后用于早期检测肾毒性的生物标志物的临床前评估。
Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1395-1408. doi: 10.1007/s00259-023-06559-9. Epub 2023 Dec 14.
6
miR-181c, a potential mediator for acute kidney injury in a burn rat model with following sepsis.miR-181c,一种潜在的介导物,可用于烧伤大鼠模型合并脓毒症的急性肾损伤。
Eur J Trauma Emerg Surg. 2023 Apr;49(2):1035-1045. doi: 10.1007/s00068-022-02124-5. Epub 2022 Oct 13.
7
Absence of significant association of trace elements in nails with urinary KIM-1 biomarker among residents of Addis Ababa in Upper Awash Basin, Ethiopia: a cross-sectional study.在埃塞俄比亚上沃什流域的亚的斯亚贝巴居民中,指甲中的微量元素与尿 KIM-1 生物标志物之间没有显著关联:一项横断面研究。
Biometals. 2022 Dec;35(6):1341-1358. doi: 10.1007/s10534-022-00448-8. Epub 2022 Sep 27.
8
Urinary NGAL, IGFBP-7, and TIMP-2: novel biomarkers to predict contrast medium-induced acute kidney injury in children.尿中性粒细胞明胶酶相关脂质运载蛋白、胰岛素样生长因子结合蛋白 7 和金属蛋白酶组织抑制剂 2:预测儿童造影剂诱导急性肾损伤的新型生物标志物。
Ren Fail. 2022 Dec;44(1):1201-1206. doi: 10.1080/0886022X.2022.2075277.
9
Advances in the study of subclinical AKI biomarkers.亚临床急性肾损伤生物标志物的研究进展
Front Physiol. 2022 Aug 24;13:960059. doi: 10.3389/fphys.2022.960059. eCollection 2022.
10
uNGAL Predictive Value for Serum Creatinine Decrease in Critically Ill Children.尿中性粒细胞明胶酶相关脂质运载蛋白对危重症患儿血清肌酐降低的预测价值。
Healthcare (Basel). 2022 Aug 19;10(8):1575. doi: 10.3390/healthcare10081575.